India Medtronic Private Limited – ‘i-Port Advance’
In December 2016, We have entered into a distribution agreement with India Medtronic Private Limited for the distribution, marketing and promotion of the ‘i-Port Advance’ injection port which requires less injections than standard insulin delivery methods.
Life with Insulin is the ultimate stage of any diabetes patient which compels a patient to prick himself before every meal. Apart from physical impact of prick, it also poses emotional challenge to individual, resulting in fear, anxiety and cognitive stress. Our compassion towards diabetes patients motivated us to launch the breakthrough iPort advance- an Insulin delivery device which takes the pricks for the patients. This novel technology helps a diabetes patient to live a normal person’s life with almost 93% less pricks.